Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · Nuveen / TIAA

Nuveen Multi Cap Value Fund Nuveen Multi Cap Value Fund - Class A (NQVAX)

Ticker NQVAX · Since 2002-12-09 · · Holdings as of Jun 30, 2026

Expense ratio
1.09%$109/yr per $10k
5-yr return
+14.1%annualized
1-yr return
+10.9%as of Dec 2025
Net assets
$1.3Ball share classes
Holdings
63

Bottom line

Is NQVAX a good fund? The bottom line

NQVAX is a share class of Nuveen Multi Cap Value Fund, a managed large value mutual fund from Nuveen / TIAA.

It charges 1.09% — about $109 a year on every $10,000 invested, more expensive than 72% of large value funds we track.

It returned +10.9% over one year, +14.1% a year over five years, +11.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.3 billion in net assets and 63 holdings, its largest position is Amazon.com Inc (3.6%) and the top 10 make up 29.4% of the portfolio.

This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.

What stands out

  • 5-year return beat 94% of category peers

What to watch

  • Expensive for its category (1.09%)
  • Front-end sales load up to 5.75%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What NQVAX invests in

The investment objective of the Fund is to provide investors with long-term capital appreciation.

Under normal circumstances, the Fund invests at least 80% of the sum of its net assets and the amount of any borrowings for investment purposes in equity securities of value companies. Value companies are those that are constituents of at least one of the following indexes on the last business day of the month in which its most recent reconstitution was completed (as adjusted by changes to an index between reconstitutions): Russell 3000 Value Index, S&P 1500 Value Index and MSCI World IMI Value Index. The Fund may invest in equity securities issued by companies with small, mid and large capitalizations. The Funds sub-adviser seeks to identify under-valued companies with a catalyst to unlock value or improve profitability. The Funds sub-adviser maintains a long-term investment view and a focus on securities it believes can appreciate over an extended time, regardless of interim…

From the fund's prospectus (filed Oct 28, 2026).

NQVAX performance

Fund calendar-year total returns, 2015–2025 2015: −6.9%; 2016: +14.4%; 2017: +18.4%; 2018: −14.6%; 2019: +30.0%; 2020: −0.5%; 2021: +28.2%; 2022: −1.3%; 2023: +15.7%; 2024: +19.0%; 2025: +17.6% −7% 2015 +14% 2016 +18% 2017 −15% 2018 +30% 2019 −1% 2020 +28% 2021 −1% 2022 +16% 2023 +19% 2024 +18% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
NQVAX+10.9%+14.1%+11.2%
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full NQVAX performance history →

What NQVAX costs

On a $10,000 investment, NQVAX's 1.09% expense ratio costs about $109 a year. The prospectus estimates $1,902 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full NQVAX fee table →

NQVAX top 10 holdings

#Holding% of fund
1Amazon.com Inc3.65%
2Intel Corp3.49%
3Citigroup Inc3.29%
4Regal Rexnord Corp3.19%
5Viasat Inc3.02%
6Flowserve Corp2.80%
7Wells Fargo & Co2.66%
8Cheniere Energy Inc2.49%
9Capital One Financial Corp2.46%
10Alphabet Inc2.30%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 29.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to NQVAX

More funds like NQVAX →

NQVAX FAQ

What is the expense ratio of NQVAX?
NQVAX's expense ratio is 1.09%, which works out to about $109 a year for every $10,000 invested. The prospectus estimates total costs of $1,902 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is NQVAX a good investment?
It depends on your goals, but the data points to: 5-year return beat 94% of category peers; expensive for its category (1.09%); front-end sales load up to 5.75%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does NQVAX hold?
NQVAX's largest holdings are Amazon.com Inc (3.6%), Intel Corp (3.5%), Citigroup Inc (3.3%), Regal Rexnord Corp (3.2%), Viasat Inc (3.0%). It holds 63 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is NQVAX's 5-year return?
NQVAX returned +14.1% a year over the five years ending Dec 31, 2025, and +11.2% a year over ten years. Past performance does not guarantee future results.
Does NQVAX have a sales load?
Yes. NQVAX has a maximum front-end sales charge of 5.75%.
Who manages NQVAX?
NQVAX is offered by Nuveen / TIAA through Nuveen Investment Trust.